Harnessing gastrointestinal organoids for cancer therapy
Trends Mol Med. 2024 Apr 13:S1471-4914(24)00065-0. doi: 10.1016/j.molmed.2024.03.010. Online ahead of print.ABSTRACTGastrointestinal organoids have emerged as a model system that authentically recapitulates the in vivo situation. Despite biomedical and technical challenges, self-assembled 3D structures derived from pluripotent stem cells or healthy and diseased tissues have proved to be invaluable tools for cancer drug discovery, disease modeling, and studying infection with carcinogenic pathogens.PMID:38616435 | DOI:10.1016/j.molmed.2024.03.010
Source: Molecular Medicine - Category: Molecular Biology Authors: Gunter Maubach Michael Naumann Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Gastroenterology | Molecular Biology | Stem Cell Therapy | Stem Cells